Calcified Pilocytic Astrocytomas and Calcifying Pseudoneoplasms of the Neuraxis: A Diagnostic Challenge

  • 0Department of Pediatric Neurology, Hospital Angeles Universidad, Mexico City, MEX.

|

|

Summary

This summary is machine-generated.

Pilocytic astrocytoma with calcifications may represent calcifying pseudoneoplasms of the neuraxis (CAPNON), challenging traditional classifications. This finding suggests new diagnostic and therapeutic approaches for these central nervous system tumors.

Area Of Science

  • Neuro-oncology
  • Pathology
  • Immunohistochemistry

Background

  • Pilocytic astrocytoma (PA) is the most common central nervous system (CNS) tumor, often exhibiting calcifications.
  • Calcifications in PA are typically associated with benign or indolent growth patterns.

Purpose Of The Study

  • To investigate the calcified attributes of pilocytic astrocytoma (PA) with calcifications and psammoma bodies (PB).
  • To explore potential reclassification of these tumors, possibly as calcifying pseudoneoplasms of the neuraxis (CAPNON).

Main Methods

  • Retrospective analysis of seven histopathologically diagnosed cases of pilocytic astrocytoma with calcifications and psammoma bodies.
  • Histological examination and immunohistochemical analysis, including glial fibrillary acidic protein (GFAP), vimentin, osteopontin, epidermal growth factor receptors (EGFR), tumor necrosis factor-alpha (TNF-α), and interleukin 1 beta (IL-1β).

Main Results

  • Calcifications showed positive reactivity for GFAP, osteoconduction, and osteopontin.
  • Hyaline bodies exhibited an atypical immune profile: negative for vimentin and GFAP, but positive for EGFR, TNF-α, and IL-1β.
  • Recurrence in four cases despite overall survival, questioning the conventional PA classification.

Conclusions

  • The atypical immune profile and recurrence patterns suggest that some calcified pilocytic astrocytomas may actually be calcifying pseudoneoplasms of the neuraxis (CAPNON).
  • This study highlights the complex interplay between PA and CAPNON, necessitating a re-evaluation of diagnostic criteria.
  • Findings may lead to novel diagnostic and therapeutic strategies in neuro-oncology for these challenging tumors.